<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32376092</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2173-5727</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Medicina intensiva</Title><ISOAbbreviation>Med Intensiva (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>General care in the management of severe traumatic brain injury: Latin American consensus.</ArticleTitle><Pagination><StartPage>500</StartPage><EndPage>508</EndPage><MedlinePgn>500-508</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medin.2020.01.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0210-5691(20)30060-7</ELocationID><Abstract><AbstractText>Severe traumatic brain injury (sTBI) remains prevalent in the young adult population. Indeed, far from descending, the incidence of sTBI remains high. One of the key bases of treatment is to avoid, detect and correct secondary injuries of systemic origin, which aggravate the primary lesion. Much of this can be achieved by maintaining an adequate physiological microenvironment allowing recovery of the damaged brain tissue. General care measures are nonspecific actions designed to meet that objective. The available guidelines on the management of sTBI have not included the topics contemplated in this consensus. In this regard, a group of members of the Latin American Brain Injury Consortium (LABIC), involved in the different aspects of the acute management of sTBI (neurosurgeons, intensivists, anesthesiologists, neurologists, nurses and physiotherapists) were gathered. An exhaustive literature search was made of selected topics in the LILACS, PubMed, Embase, Scopus, Cochrane Controlled Register of Trials and Web of Science databases. To establish recommendations or suggestions with their respective strength or weakness, the GRADE methodology (Grading of Recommendations, Assessment, Development and Evaluation) was applied. Additionally, certain recommendations (included in complementary material) were not assessed by GRADE, because they constitute a set of therapeutic actions of effective compliance, in which it was not possible to apply the said methodology. Thirty-two recommendations were established, 16 strong and 16 weak, with their respective levels of evidence. This consensus attempts to standardize and establish basic general care measures in this particular patient population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Espa&#xf1;a, S.L.U. y SEMICYUC. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Godoy</LastName><ForeName>D A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Unidad de Cuidados Neurointensivos, Sanatorio Pasteur, San Fernando del Valle de Catamarca, Catamarca, Argentina; Unidad de Cuidados Intensivos, Hospital San Juan Bautista, San Fernando del Valle de Catamarca, Catamarca, Argentina. Electronic address: dagodoytorres@yahoo.com.ar.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Videtta</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Unidad de Cuidados Intensivos, Hospital Nacional Alejandro Posadas, Unidad de Cuidados Intensivos Hospital Eva Per&#xf3;n, Merlo, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santa Cruz</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unidad de Terapia Intensiva, Hospital Regional R&#xed;o Gallegos, R&#xed;o Gallegos, Santa Cruz, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Escuela de Medicina, Universidad de Magallanes, Punta Arenas, Magallanes, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilera-Rodr&#xed;guez</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Servicio Neurocirug&#xed;a, Hospital Naval Almirante Nef. Vi&#xf1;a del Mar, Universidad de Valpara&#xed;so, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carre&#xf1;o-Rodr&#xed;guez</LastName><ForeName>J N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Unidad de Cuidados Intensivos y Servicio Neurocirug&#xed;a, Fundaci&#xf3;n Santa Fe de Bogot&#xe1;, Universidad del Rosario, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciccioli</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unidad Terapia Intensiva, Hospital Municipal de Agudos &#xab;Dr. Le&#xf3;nidas Lucero&#xbb;, Universidad Nacional del Sur, Bah&#xed;a Blanca, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pi&#xf1;ero</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unidad Terapia Intensiva, Hospital Municipal de Agudos &#xab;Dr. Le&#xf3;nidas Lucero&#xbb;, Universidad Nacional del Sur, Bah&#xed;a Blanca, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciro</LastName><ForeName>J D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Anestesia y Cuidados Intensivos, Cl&#xed;nica Las Am&#xe9;ricas Auna, Medell&#xed;n, Antioquia, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Re-Guti&#xe9;rrez</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unidad de Terapia Intensiva Adultos, Hospital Materno Infantil C.N.S0, La Paz, Bolivia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Domeniconi</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unidad de Cuidados Intensivos, Sanatorio de la Trinidad San Isidro, San Isidro, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Unidad de Paciente Critico Adulto, Cl&#xed;nica Universidad de los Andes, Santiago de Chile, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Unidad de Cuidados Intensivos, Cl&#xed;nica Medell&#xed;n, Medell&#xed;n, Antioquia, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacerda-Gallardo</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Departamento de Neurocirug&#xed;a, Hospital General Docente &#xab;Roberto Rodr&#xed;guez&#xbb;, Mor&#xf3;n, Ciego de &#xc1;vila, Cuba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mej&#xed;a</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unidad de Cuidados Neurointensivos, Fundaci&#xf3;n Valle del Lili, Cali, Valle del Cauca, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panhke</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Shock Room, Hospital Municipal de Urgencias, C&#xf3;rdoba, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Departamento de Medicina, Unidad de Pacientes Cr&#xed;ticos, Hospital Cl&#xed;nico Universidad de Chile, Santiago de Chile, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lora</LastName><ForeName>F S</ForeName><Initials>FS</Initials><AffiliationInfo><Affiliation>Universidad Mayor de San Andr&#xe9;s, La Paz, Bolivia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soler-Morej&#xf3;n</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital Cl&#xed;nico Quir&#xfa;rgico &#xab;Hermanos Ameijeiras&#xbb;, La Habana, Cuba.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sufan</LastName><ForeName>J L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Unidad de Paciente Neurocr&#xed;tico, Cl&#xed;nica Indisa, Escuela de Kinesiolog&#xed;a, Facultad de Ciencias de la Rehabilitaci&#xf3;n, Universidad Andres Bello, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montes</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Unidad de Paciente Cr&#xed;tico, Cl&#xed;nica Alemana, Santiago de Chile, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuenzalida</LastName><ForeName>L C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Departamento Medicina, Pontificia Universidad Cat&#xf3;lica de Chile, Centro de Pacientes Cr&#xed;ticos, Complejo Hospitalario Barros Luco Trudeau, Santiago de Chile, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parahnos</LastName><ForeName>J L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Unidad de Terapia Intensiva y Servicio de Neurocirug&#xed;a, Hospital de la Santa Casa, S&#xe3;o Jo&#xe3;o del-Rei, Minas Gerais, Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jibaja</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unidad de Cuidados Intensivos, Hospital Eugenio Espejo, Escuela de Medicina, Universidad Internacional del Ecuador, Quito, Ecuador.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>en representaci&#xf3;n del Consorcio Latinoamericano de Injuria Cerebral (LABIC)</CollectiveName></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Cuidados generales en el manejo del traumatismo craneoencef&#xe1;lico grave: consenso latinoamericano.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Med Intensiva (Engl Ed)</MedlineTA><NlmUniqueID>101717568</NlmUniqueID><ISSNLinking>2173-5727</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Consenso</Keyword><Keyword MajorTopicYN="N">Consensus</Keyword><Keyword MajorTopicYN="N">Cuidados generales</Keyword><Keyword MajorTopicYN="N">General care</Keyword><Keyword MajorTopicYN="N">Homeostasis</Keyword><Keyword MajorTopicYN="N">Lesi&#xf3;n secundaria</Keyword><Keyword MajorTopicYN="N">Neuroprotecci&#xf3;n fisiol&#xf3;gica</Keyword><Keyword MajorTopicYN="N">Physiological neuroprotection</Keyword><Keyword MajorTopicYN="N">Secondary injury</Keyword><Keyword MajorTopicYN="N">Traumatic brain injury</Keyword><Keyword MajorTopicYN="N">Traumatismo craneoencef&#xe1;lico</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32376092</ArticleId><ArticleId IdType="doi">10.1016/j.medin.2020.01.014</ArticleId><ArticleId IdType="pii">S0210-5691(20)30060-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31370942</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>30</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-3278</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Season>Jul-Sep</Season></PubDate></JournalIssue><Title>Rehabilitacion</Title><ISOAbbreviation>Rehabilitacion (Madr)</ISOAbbreviation></Journal><ArticleTitle>[Bromocriptine in disorders of consciouness due to traumatic brain injury].</ArticleTitle><Pagination><StartPage>155</StartPage><EndPage>161</EndPage><MedlinePgn>155-161</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rh.2019.03.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0048-7120(19)30029-5</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The aim of this study was to assess the results and adverse effects of bromocriptine in patients with traumatic brain injury-vegetative state (TBI-VS) or traumatic brain injury-minimally conscious state (TBI-MCS).</AbstractText><AbstractText Label="METHODS">We conducted a retrospective review of 10 patients, six with TBI-VS and four with TBI-MCS. All patients received bromocriptine at a starting dose of 2.5mg twice daily. Bromocriptine was titrated up to 7.5 or 12.5mg twice daily according to response and was maintained for at least 4 weeks. Various assessment scales were used in the following stages: before bromocriptine administration, at 4 weeks post bromocriptine prescription, and at hospital discharge. The assessment scales used were the Coma Recovery Scale-Revised (CRS-R), Disability Rating Scale, Glasgow Coma Scale, Barthel Scale, and Marshall Scale.</AbstractText><AbstractText Label="RESULTS">Of the 10 patients, four with TBI-MCS and four with TBI-VS achieved a score of 23 points at discharge in the CRS-R, thus emerging from VS or MCS and regaining functional status. There were only two patients who emerged from VS but remained in MCS (8 to 11 and 5 to 10 points in CRS-R).</AbstractText><AbstractText Label="CONCLUSIONS">Considering the poor prognosis for recovery in these patients, bromocriptine use has a positive risk-benefit ratio at a dosage of at least 7.5mg twice daily for 4 weeks.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Sociedad Espa&#xf1;ola de Rehabilitaci&#xf3;n y Medicina F&#xed;sica. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Otero Villaverde</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Complexo Hospitalario Universitario A Coru&#xf1;a, La Coru&#xf1;a, Espa&#xf1;a. Electronic address: Sergiooterov@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin Mourelle</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Complexo Hospitalario Universitario A Coru&#xf1;a, La Coru&#xf1;a, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crespo Lopez</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Complexo Hospitalario Universitario A Coru&#xf1;a, La Coru&#xf1;a, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrera Sarmiento</LastName><ForeName>J J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Complexo Hospitalario Universitario A Coru&#xf1;a, La Coru&#xf1;a, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz Castillo</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Complexo Hospitalario Universitario A Coru&#xf1;a, La Coru&#xf1;a, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canosa Hermida</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Complexo Hospitalario Universitario A Coru&#xf1;a, La Coru&#xf1;a, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Uso de bromocriptina en pacientes con alteraci&#xf3;n de conciencia secundaria a traumatismo craneoencef&#xe1;lico.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rehabilitacion (Madr)</MedlineTA><NlmUniqueID>7802471</NlmUniqueID><ISSNLinking>0048-7120</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002491">Central Nervous System Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>3A64E3G5ZO</RegistryNumber><NameOfSubstance UI="D001971">Bromocriptine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070642" MajorTopicYN="N">Brain Injuries, Traumatic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001971" MajorTopicYN="N">Bromocriptine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002491" MajorTopicYN="N">Central Nervous System Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020207" MajorTopicYN="N">Coma, Post-Head Injury</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003244" MajorTopicYN="N">Consciousness Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018458" MajorTopicYN="N">Persistent Vegetative State</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015599" MajorTopicYN="N">Trauma Severity Indices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bromocriptina</Keyword><Keyword MajorTopicYN="N">Bromocriptine</Keyword><Keyword MajorTopicYN="N">Estado de m&#xed;nima conciencia</Keyword><Keyword MajorTopicYN="N">Minimally conscious state</Keyword><Keyword MajorTopicYN="N">S&#xed;ndrome vigilia sin respuesta</Keyword><Keyword MajorTopicYN="N">Traumatic brain injury</Keyword><Keyword MajorTopicYN="N">Traumatismo craneoencef&#xe1;lico</Keyword><Keyword MajorTopicYN="N">Vegetative state</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31370942</ArticleId><ArticleId IdType="doi">10.1016/j.rh.2019.03.001</ArticleId><ArticleId IdType="pii">S0048-7120(19)30029-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28365031</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-6749</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>8</Issue><PubDate><Year>2017</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Medicina intensiva</Title><ISOAbbreviation>Med Intensiva</ISOAbbreviation></Journal><ArticleTitle>Secondary decompressive craniectomy for the management of refractory endocraneal hypertension in severe traumatic brain injury. Lights and shadows from recent studies.</ArticleTitle><Pagination><StartPage>487</StartPage><EndPage>490</EndPage><MedlinePgn>487-490</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medin.2017.02.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0210-5691(17)30063-3</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Godoy</LastName><ForeName>D A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Unidad de Cuidados Neurointensivos, Sanatorio Pasteur, San Fernando del Valle de Catamarca, Argentina; Unidad de Terapia Intensiva, Hospital San Juan Bautista, San Fernando del Valle de Catamarca, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moscote Zalazar</LastName><ForeName>L R</ForeName><Initials>LR</Initials><AffiliationInfo><Affiliation>Unidad de Paciente Cr&#xed;tico, Cl&#xed;nica Universitaria de Puerto Montt, Puerto Montt, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rubiano</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Neurocirug&#xed;a, Universidad El Bosque, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz-S&#xe1;nchez</LastName><ForeName>&#xc1;</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario Virgen del Roc&#xed;o, Sevilla, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lubillo</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unidad de Medicina Intensiva, Hospital Universitario Ntra. Sra. de Candelaria, Santa Cruz de Tenerife, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murillo-Cabezas</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Intensiva, Hospital Universitario Virgen del Roc&#xed;o, Sevilla, Espa&#xf1;a. Electronic address: franciscomurillocabezas@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 TW009332</GrantID><Acronym>TW</Acronym><Agency>FIC NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Craniectom&#xed;a descompresiva secundaria para el manejo de la hipertensi&#xf3;n endocraneanal refractaria en el traumatismo craneoencef&#xe1;lico grave. Luces y sombras de los estudios recientes.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Med Intensiva</MedlineTA><NlmUniqueID>9207689</NlmUniqueID><ISSNLinking>0210-5691</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001463">Barbiturates</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001463" MajorTopicYN="N">Barbiturates</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001929" MajorTopicYN="N">Brain Edema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000070642" MajorTopicYN="N">Brain Injuries, Traumatic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002560" MajorTopicYN="N">Cerebrovascular Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056424" MajorTopicYN="N">Decompressive Craniectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019586" MajorTopicYN="N">Intracranial Hypertension</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018401" MajorTopicYN="N">Sample Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28365031</ArticleId><ArticleId IdType="doi">10.1016/j.medin.2017.02.002</ArticleId><ArticleId IdType="pii">S0210-5691(17)30063-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25086884</PMID><DateCompleted><Year>2017</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2017</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1989-7286</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><Issue>9</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Archivos de la Sociedad Espanola de Oftalmologia</Title><ISOAbbreviation>Arch Soc Esp Oftalmol</ISOAbbreviation></Journal><ArticleTitle>[Monocular non-organic visual loss after a cranioencephalic trauma].</ArticleTitle><Pagination><StartPage>448</StartPage><EndPage>449</EndPage><MedlinePgn>448-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.oftal.2014.04.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0365-6691(14)00149-X</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nieves-Moreno</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unidad de Neurooftalmolog&#xed;a, Servicio de Oftalmolog&#xed;a, Instituto de Investigaci&#xf3;n Sanitaria del Hospital Cl&#xed;nico San Carlos (IdISSC), Madrid, Espa&#xf1;a. Electronic address: marianievesmoreno@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos-Bueso</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unidad de Neurooftalmolog&#xed;a, Servicio de Oftalmolog&#xed;a, Instituto de Investigaci&#xf3;n Sanitaria del Hospital Cl&#xed;nico San Carlos (IdISSC), Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;enz-Franc&#xe9;s</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unidad de Neurooftalmolog&#xed;a, Servicio de Oftalmolog&#xed;a, Instituto de Investigaci&#xf3;n Sanitaria del Hospital Cl&#xed;nico San Carlos (IdISSC), Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Feijoo</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Unidad de Neurooftalmolog&#xed;a, Servicio de Oftalmolog&#xed;a, Instituto de Investigaci&#xf3;n Sanitaria del Hospital Cl&#xed;nico San Carlos (IdISSC), Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><VernacularTitle>P&#xe9;rdida visual no org&#xe1;nica monocular secundaria a traumatismo craneoencef&#xe1;lico.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2014</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Arch Soc Esp Oftalmol</MedlineTA><NlmUniqueID>1304603</NlmUniqueID><ISSNLinking>0365-6691</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000063" MajorTopicYN="N">Accidents, Traffic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001766" MajorTopicYN="N">Blindness</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003941" MajorTopicYN="N">Diagnostic Techniques, Ophthalmological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005131" MajorTopicYN="N">Eye Injuries</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005162" MajorTopicYN="N">Factitious Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012607" MajorTopicYN="N">Scotoma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013001" MajorTopicYN="N">Somatoform Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015348" MajorTopicYN="N">Vision, Binocular</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058609" MajorTopicYN="N">Visual Field Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25086884</ArticleId><ArticleId IdType="doi">10.1016/j.oftal.2014.04.009</ArticleId><ArticleId IdType="pii">S0365-6691(14)00149-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24793091</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2016</Year><Month>12</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-6749</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>8</Issue><PubDate><Year>2014</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Medicina intensiva</Title><ISOAbbreviation>Med Intensiva</ISOAbbreviation></Journal><ArticleTitle>[Multimodal neuromonitoring in traumatic brain injury: contribution of PTiO2].</ArticleTitle><Pagination><StartPage>513</StartPage><EndPage>521</EndPage><MedlinePgn>513-21</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medin.2014.02.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0210-5691(14)00049-7</ELocationID><Abstract><AbstractText>The main goal of exhaustively monitoring neurocritical patients is to avoid secondary injury. In the last few years we have witnessed an increase in brain monitoring tools, beyond the checking of intracranial and brain perfusion pressures. These widely used systems offer valuable but possibly insufficient information. Awareness and correction of brain hypoxia is a useful and interesting measure, not only for diagnostic purposes but also when deciding treatment, and to predict an outcome. In this context, it would be of great interest to use all the information gathered from brain oxygenation monitoring systems in conjunction with other available multimodal monitoring devices, in order to offer individualized treatment for each patient.</AbstractText><CopyrightInformation>Copyright &#xa9; 2013 Elsevier Espa&#xf1;a, S.L.U. and SEMICYUC. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dom&#xed;nguez-Berrot</LastName><ForeName>A M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Centro Asistencial Universitario, Le&#xf3;n, Espa&#xf1;a. Electronic address: adominguezb@saludcastillayleon.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Vaquero</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro Asistencial Universitario, Le&#xf3;n, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;az-Dom&#xed;nguez</LastName><ForeName>F J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Centro Asistencial Universitario, Le&#xf3;n, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robla-Costales</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centro Asistencial Universitario, Le&#xf3;n, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Neuromonitorizaci&#xf3;n multimodal en el TCE: aportaci&#xf3;n de la PTiO2.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2014</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Med Intensiva</MedlineTA><NlmUniqueID>9207689</NlmUniqueID><ISSNLinking>0210-5691</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000740" MajorTopicYN="N">Anemia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016913" MajorTopicYN="N">Blood Component Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070642" MajorTopicYN="N">Brain Injuries, Traumatic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005110" MajorTopicYN="N">Extracellular Space</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002534" MajorTopicYN="N">Hypoxia, Brain</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020925" MajorTopicYN="N">Hypoxia-Ischemia, Brain</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008991" MajorTopicYN="N">Monitoring, Physiologic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="N">Oxygen Inhalation Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010313" MajorTopicYN="N">Partial Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014661" MajorTopicYN="N">Vasoconstriction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain tissue oxygen pressure</Keyword><Keyword MajorTopicYN="N">Cerebral hypoxia: Brain oxygenation</Keyword><Keyword MajorTopicYN="N">Hipoxia cerebral</Keyword><Keyword MajorTopicYN="N">Lesi&#xf3;n secundaria</Keyword><Keyword MajorTopicYN="N">Monitorizaci&#xf3;n multimodal</Keyword><Keyword MajorTopicYN="N">Multimodality monitoring</Keyword><Keyword MajorTopicYN="N">Neuromonitoring</Keyword><Keyword MajorTopicYN="N">Neuromonitorizaci&#xf3;n</Keyword><Keyword MajorTopicYN="N">Oxigenaci&#xf3;n cerebral</Keyword><Keyword MajorTopicYN="N">Presi&#xf3;n tisular cerebral de ox&#xed;geno</Keyword><Keyword MajorTopicYN="N">Secondary insult</Keyword><Keyword MajorTopicYN="N">Traumatic brain injury</Keyword><Keyword MajorTopicYN="N">Traumatismo craneoencef&#xe1;lico</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24793091</ArticleId><ArticleId IdType="doi">10.1016/j.medin.2014.02.005</ArticleId><ArticleId IdType="pii">S0210-5691(14)00049-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>